---
title: "GALNS"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Gene: GALNS"
tags: ['GALNS', 'GeneticInformation', 'Enzyme', 'MPSIVA', 'Treatment', 'Prognosis', 'DrugResponse', 'RelatedPapers']
---

## Gene: GALNS

### Genomic location
- The GALNS gene is located on the long arm of chromosome 16 (16q24.3)

### Function
- The GALNS gene codes for the enzyme N-acetylgalactosamine-6-sulfatase (GALNS)
- GALNS is responsible for breaking down certain complex sugars called glycosaminoglycans (GAGs) in the body

### External IDs and aliases
- HGNC: 4169
- NCBI Entrez: 2588
- Ensembl: ENSG00000157933
- OMIM: 612222
- UniProtKB/Swiss-Prot: P34059
- Aliases: N-acetylgalactosamine-6-sulfate sulfatase, sulfatase, galactose-6-O-sulfate sulfatase

### AA mutation list and mutation type with dbSNP ID
- p.Ser66Leu (rs17095529)
- p.Phe198ser (rs2277)
- p.Arg386Cys (rs2233876)
- p.Arg386His (rs2233877)
- p.Arg386Trp (rs121912827)

### Somatic SNVs/InDels with dbSNP ID
- No somatic SNVs/InDels have been identified for the GALNS gene

### Related diseases
- Mucopolysaccharidosis type IVA (MPS IVA) or Morquio A syndrome
- Mucopolysaccharidosis type IVB (MPS IVB)

### Treatment and prognosis
- Treatment is primarily symptomatic and supportive, and may include surgical interventions and enzyme replacement therapy
- Prognosis varies depending on disease severity and age of diagnosis

### Drug response
- Enzyme replacement therapy with the drug Vimizim (elosulfase alfa) has been approved for the treatment of MPS IVA

### Related papers
- Subject: Morquio A syndrome
- Author: Monta√±o AM, Tomatsu S, Gottesman GS, Smith M, Orii T
- DOI: 10.1016/j.ymgme.2007.05.006

- Subject: Enzyme replacement therapy
- Author: Hendriksz CJ, Harmatz P, Beck M, Jones S, Wood T, Lachman R, Gravance CG, Orii T, Tomatsu S
- DOI: 10.1016/j.ymgme.2012.03.012

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**